Myriad Genetics MYGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$34.1M-34,000% | -$7.9M+81.4% | -$27.4M-24.0% | -$330.5M-801% | -$100K+99.6% | ||
| $12.5M-13.2% | $12.6M-14.9% | $12.6M-19.2% | $14.1M-6.6% | $14.4M-8.3% | ||
| $6.5M-31.6% | $2.8M-74.3% | $12.2M-1.6% | $10.7M-26.2% | $9.5M-20.8% | ||
| -$15.7M+3.7% | $10.6M— | $21.1M— | -$13.6M— | -$16.3M+12.4% | ||
| -$6.5M+21.7% | -$6M-1.7% | -$6.2M— | -$6.9M-7.8% | -$8.3M-16.9% | ||
| $0-100% | —— | —— | —— | $40M-33.3% | ||
| $0-100% | —— | $60M+200% | —— | $20.5M-65.8% | ||
| -$3M-122% | —— | $56.2M+1,913% | $2.6M— | $13.6M+255% | ||
| -$25.3M-132% | $0— | $71.1M— | -$17.3M-293% | -$10.9M+69.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
